Navigation Links
Agent in Biological Technology

Sanofi-aventis U.S. Introduces BenzaClin(R) Carekit

... patients with acne who want to add a moisturizing agent to their skin care regimen. The BenzaClin ... their patients who are seeking a moisturizing agent while using BenzaClin for their acne," says Brent ... Viscontour(R) Serum is a cosmetic hydration agent that offers you a simple and convenient way of ...

AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma

... bortezomib (VELCADE(R)) and an immunomodulatory agent (REVLIMID(R) or THALIDOMID(R)) and previously ... is a novel, first-in-class, oral anti-cancer agent that modulates several key signal transduction ... cancer cells. Perifosine has demonstrated single agent anti-tumor activity in Phase 1 and Phase 2 ...

New MRI technique could mean fewer breast biopsies in high-risk women

... a half hour, the technician injects a contrast agent into a vein in the patient's arm. Over time, the contrast agent flows throughout the body, including the breasts. ... often have immature vasculature, and the contrast agent flows in and "leaks" out quickly. Conversely, ...

VisEn Launches New Cat-K FAST(TM) Fluorescence Molecular Imaging Agent

... launch of its new Cat-K FAST (TM) imaging agent for measuring and monitoring Cathepsin K activity ... in atherosclerosis. The new Cat-K FAST (TM) agent is expected to significantly expand research and ... (TM) represents an additional protease-sensing agent developed and commercially launched based on ...

Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia

... cent) Elacytarabine is a novel cytotoxic agent being developed by Clavis Pharma for the ... of cytarabine, an established anti-cancer agent often used in acute myeloid leukaemia. Unlike ... II trial, Elacytarabine was given as a single agent to patients with late stage AML who had received ...

AEterna Zentaris Discloses Preliminary Phase 2 Trial Results for Perifosine in Combination with Radiotherapy for Non-Small Cell Lung Cancer

... is a novel, first-in-class, oral anti-cancer agent that modulates several key signal transduction ... cancer cells. Perifosine has demonstrated single agent anti-tumor activity in Phase 1 and Phase 2 studies and is currently being studied as a single agent and in combination with several forms of ...

Cell Therapeutics Amends and Restates Its 'Modified Dutch Auction' Tender Offer to a Fixed Price Tender Offer for Any and All of Its $118.9 Million Outstanding Convertible Notes

... is Piper Jaffray & Co., the information agent for the Exchange Offers is Georgeson Inc. and the ... of charge, from Georgeson Inc., the information agent for the Exchange Offers. While CTI's board ... directors, the financial advisor, the information agent or the depositary makes any recommendation to any ...

Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes

... Offer is Piper Jaffray & Co., the information agent for the Exchange Offer is Georgeson Inc. and the ... of charge, from Georgeson Inc., the information agent for the Exchange Offer. While CTI's board of ... directors, the financial advisor, the information agent or the depositary makes any recommendation to any ...

Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer

... offer is Piper Jaffray & Co., the information agent for the exchange offer is Georgeson Inc. and the ... of charge, from Georgeson Inc., the information agent for the Exchange Offer. Holders of the Notes ... exchange offer documents may call the information agent at (888) 337-7699. Banks and brokerage firms may ...

Ascenta Therapeutics Announces Results of Preclinical Evaluation of AT-406 in Multiple Cancer Models

... - Data on novel pro-apoptotic agent presented at the 100th Annual Meeting of the ... demonstrated that AT-406 was active as a single agent in vitro in a number of cell lines, including ... in those cell lines. "AT-406 is the second agent in our development pipeline to demonstrate broad ...

VisEn Launches Next-Generation Fast ('Fluorescence Activatible Sensor Technology') Agent Platform for Expanded Performance in Imaging Disease Biomarkers In Vivo

... Activatible Sensor Technology") imaging agent platform for advanced imaging of key ... FAST as a fast-acting, near-infrared imaging agent to measure tumor MMP activity in vivo and ... efficacy. In the study, administration of the agent allowed the non-invasive measurement of MMP ...

Cytopia Presentation on VDA CYT997 at AACR Conference

... data on its anticancer vascular disrupting agent (VDA) CYT997 at the forthcoming 100th Annual ... mode of action of a Phase II vascular disrupting agent outlines extensive preclinical data for CYT997 ... drug candidate is CYT997, a vascular disrupting agent (VDA) for the treatment of various cancers, which ...

Cylene Pharmaceuticals Initiates Phase II Clinical Trial of Quarfloxin (CX-3543) in Patients With Carcinoid/Neuroendocrine Tumors

... the nucleolus, but quarfloxin is the first agent designed to directly target a key function within ... About Quarfloxin (CX-3543), a Nucleolus Targeting agent (NTA) Quarfloxin is a ground-breaking ... modulators, but quarfloxin is the first agent to directly target this cancer-specific aberrant ...

Exposure to Agent Orange linked to prostate cancer in Vietnam veterans

... showing that Vietnam War veterans exposed to agent Orange have greatly increased risks of prostate ... for the disease. "While others have linked agent Orange to cancers such as soft-tissue sarcomas, ... study to date of Vietnam War veterans exposed to agent Orange and the incidence of prostate cancer." ...

Exposure to Agent Orange linked to prostate cancer in Vietnam veterans

... showing that Vietnam War veterans exposed to agent Orange have greatly increased risks of prostate ... for the disease. "While others have linked agent Orange to cancers such as soft-tissue sarcomas, ... study to date of Vietnam War veterans exposed to agent Orange and the incidence of prostate cancer." ...

BioElectronics Corp. Announces $400,000 in New Orders From the Middle East

... New Sales agent and Distributor Gains Quick Traction in the ... (BIEL) announced today that the new sales agent it announced last week, Abdulkader Al-Mehyar ... Eastern region. "We are pleased that the new agent has hit the ground running and is finding wide ...

VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent

... its IntegriSenseTM fluorescence in vivo imaging agent product line. The agent is the first product developed out of the ... vascularity and angiogenesis. The agent was developed to enable in vivo imaging of ...

4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis

... it has appointed FBI Supervising Special agent (Ret.) Dr. Philip Hayden as its Vice President, ... 1970s, Dr. Hayden worked as a Supervisory Special agent for the Federal Bureau of Investigation as a case agent where he was involved in criminal cases, ...

China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008

... & Trust Company ("AST") as its new transfer agent and registrar, effective August 15, 2008. AST, ... New York, replaces the Company's former transfer agent and registrar, American Registrar & Transfer ... to be the largest independent stock transfer agent in the United States. Stockholders seeking ...

FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions

... First Organ-specific MRI Contrast agent Approved in the United States in ... EOVIST is a paramagnetic MRI contrast agent that combines features of both an extracellular contrast agent and a hepatocyte-specific agent. EOVIST is ...

Astellas Launches Lexiscan(TM) (Regadenoson) Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging (MPI)

... agonist, for use as a pharmacologic stress agent in radionuclide MPI -- a test that detects and ... be safe and effective as a pharmacologic stress agent in MPI studies. The A2A adenosine ... For these patients, a pharmacologic stress agent that temporarily increases blood flow through the ...

Commercial Launch of Lexiscan(TM) (Regadenoson) Injection Triggers $10 Million Milestone Payment from TPG-Axon Capital to CV Therapeutics

... agonist, for use as a pharmacologic stress agent in radionuclide myocardial perfusion ... approved for use as a pharmacologic stress agent in radionuclide MPI studies in patients unable to ... injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging in ...

AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China

... an intravenous iron replacement therapeutic agent being developed to treat iron deficiency anemia ... as an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in ... as an intravenous iron replacement therapeutic agent in chronic kidney disease patients. The Company ...

Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG

... includes CS-1008, an oncologic agent to combat malignant neoplasms, which is in Phase ... 162, which is licensed from Amgen. In Japan, this agent is currently in preparation for Phase 3 for ... CIMYM Biosciences. This is an oncologic agent in Phase 1 to treat advanced solid malignancies. ...

DuPont Expands Animal Health Solutions Business in Asia

... as the most effective virucidal disinfectant agent available, Virkon(R) S works as a preventive ... most effective virucidal disinfectant agent available. It works as a preventive measure, ... most effective virucidal disinfectant agent available. It works as a preventive measure, ...

Oncolytics Biotech Inc. Announces 2008 First Quarter Results

... sarcomas, and reovirus as a purging agent for autologous stem cell transplants. - In ... This trial is a Phase II, open-label, single agent study whose primary objective is to measure ... preclinical work using reovirus as a purging agent during autologous (harvested from the ...

CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label

... Medafor's microporous polysaccharide hemostatic agent for use in cardiac and vascular surgery in the ... as directed, this highly effective hemostatic agent facilitates the formation of a resilient, natural ... as numerous topical applications worldwide. This agent has a number of cost and safety features ...

Paloma Pharmaceuticals to Present at the American Association for Cancer Research

... dual acting anti-angiogenic and direct anti-tumor agent created through computational design, synthetic ... as an anti-angiogenic agent and anti-tumor agent is shown to reside in its ability to target ... Dual Acting Anti-angiogenic and Direct Anti-tumor agent Affecting the PI3K/Akt/mTor Pathway," was be ...

Phlo Clarifies That Pre-Reverse Split Certificates Are Negotiable in Market Transactions

... to surrender their certificates to the transfer agent in exchange for new certificates reflecting the ... split certificate is sent to Phlo's transfer agent for re-registration, the transfer agent automatically re-issues the shares on ...

CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection

... for Use as Pharmacologic Stress agent in Myocardial Perfusion Imaging- PALO ALTO, ... agonist, for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging ... be safe and effective as a pharmacologic stress agent in MPI studies. Lexiscan is delivered as a rapid ...

Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo

... Rexin-G demonstrates profound single agent efficacy in a broad spectrum of chemotherapy ... based on its performance as a single therapeutic agent in treating chemotherapy refractory pancreatic ... of safety and efficacy as an anti-cancer agent in a broad spectrum of chemo- resistant tumors, ...

EntreMed Announces 2008 Corporate and Clinical Program Priorities

... 2008 include reporting results for the single agent MKC-1 MBC study (2Q08); presentation of ... ENMD-1198 is a potent, orally-active, antimitotic agent discovered at EntreMed that causes cell cycle ... potent antitumor activity as a single agent in multiple preclinical models, including tumor ...

PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008

... the Company's broad spectrum chemical nerve agent prophylaxis. The PK studies were conducted in ... of the Company's broad spectrum chemical nerve agent prophylaxis, Protexia(R). The contract includes a ... against acute organophosphorus (OP) nerve agent toxicity. About Chemical Weapons ...

Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team

... AML, Cloretazine(R) (VNP40101M) is an active agent in this indication. I am looking forward to ... evaluated in a pivotal Phase II trial as a single agent in elderly patients with de novo poor-risk acute ... trials of Cloretazine(R) (VNP40101M) as a single agent in small cell lung cancer, with temozolomide in ...

ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer

... a Phase I clinical trial of the novel anti-cancer agent TB-403. TB-403 is a monoclonal antibody that ... have taken this innovative anti-cancer agent to the clinical stage. TB-403 could be a novel ... for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases, including acute ...

Report recommends off-site disposal of secondary waste

... of secondary waste during regular chemical agent disposal operations, says a new report from the ... the 2003 closure of the Johnston Atoll Chemical agent Disposal System (JACADS) in the Pacific, which ... three of the five states, all waste from chemical agent disposal operations is considered hazardous, ...

New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA

... first line therapy. Daptomycin is a fast acting agent in these potentially difficult situations and is ... head-to-head study demonstrated daptomycin single agent therapy was as effective as dual agent comparator treatments and also has a favourable ...

ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402

... This antibody is a promising novel anticoagulant agent particularly because it only partially ... for at least 6 months is indicated. Therefore, an agent allowing for once-a-month treatment in ... for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases, including acute ...

ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent

... Staphylokinase.THR-100 is a thrombolytic agent developed for the treatment of acute ... look forward to moving this unique thrombolytic agent quickly into the clinic and toward ... for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases, including acute ...

Report recommends off-site disposal of secondary waste

... of secondary waste during regular chemical agent disposal operations, says a new report from the ... the 2003 closure of the Johnston Atoll Chemical agent Disposal System (JACADS) in the Pacific, which ... three of the five states, all waste from chemical agent disposal operations is considered hazardous, ...
Other Contents
(Date:12/22/2014)... 22, 2014  The 2014 Holiday Season may ... as Acuity Market Intelligence reports that the long ... open. Acuity forecasts that intensifying demand for smart ... biometrics will drive a global market of 2.5 ... by 2020.   According to ...
(Date:12/19/2014)... VEGAS , Dec. 18, 2014   LaunchKey ... built for the post-password and Internet of Things era, ... seed funding. The venture round was led by Metamorphic ... Capital, Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has ... new funding to expand its team and bring LaunchKey ...
(Date:12/17/2014)... Dec. 16, 2014 Valencell, a leader in ... biometric technology to industry leaders such as Intel, Jabra, ... validated, biometric wearable products. These products will be showcased ... Las Vegas . "Our ... flexible and robust – with the clinical data to ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
(Date:12/25/2014)... When head lice hits a home or ... to get rid of it while keeping it from taking ... now have the solution right in their neighborhood: Lice ... Troopers provides full spectrum head lice screening and treatment services ... Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and South ...
(Date:12/25/2014)... Dec. 25, 2014 (HealthDay News) -- The risk of ... holidays, so you need to be extra cautious, an ... we see a significant increase in patients coming in ... the Suffolk County Volunteer Firefighters Burn Center of Stony ... should be full of joy, but if not careful, ...
(Date:12/25/2014)... Dennis Thompson HealthDay ... Researchers could be closing in on a "fountain of youth" ... the health of older adults, a new study suggests. ... given a drug that targets a genetic signaling pathway linked ... Novartis report. The experimental medication, a version ...
(Date:12/25/2014)... “ SmileStix ” was featured on NewsWatch as ... coolest mobile applications on the iOS, Android, and Windows markets. ... conducted the app review and shared with viewers how this ... The old saying goes, “A picture says a thousand words.” ... describe a single image, because each picture holds a unique ...
(Date:12/25/2014)... Rosa, CA (PRWEB) December 25, 2014 ... department visits and 2 million hospital admissions across the ... and Prevention ). The CDC’s National Hospital Ambulatory ... departments through a survey conducted in 2010. They estimated ... department visits that resulted in a primary diagnosis of ...
Breaking Medicine News(10 mins):Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4
Other TagsOther Tags